Monday, September 4, 2023

Ergomed/Permira: buyout group sees drug trial group as contract thriller

Private equity group’s bid for researcher comes as the biomedical market is slowing down post-Covid
http://dlvr.it/SvcgdR
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

The barbell tolls for fixed income investing

A trend long associated with equity investing is now playing out in the bond markets http://dlvr.it/TDc3ZC